“Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients With COVID -19”. 2022. Journal of Pharmaceutical Negative Results 13 (2): 82-86. https://pnrjournal.com/index.php/home/article/view/199.